Anti-Infective Drugs Advisory Committee

 

October 28, 2003 (afternoon session)

 

Additional Meeting Participants

 

 

Acting Industry Representative (non-voting)

 

Kenneth R. Brown, M.D.

Independent Consultant on Vaccines, Antibiotics, and Tropical Medicine

8111 Winston Road

Philadelphia, Pennsylvania 19118

 

 

Consultants (voting)

 

Janet D. Elashoff, Ph.D.

Director, Division of Biostatistics

Cedars-Sinai Medical Center

8700 Beverly Boulevard

Los Angeles, California 90048

 

Joan F. Hilton, Sc.D., M.P.H. (Consultant Center for Biologics Evaluation and Research)

Associate Professor of Biostatistics

Department of Epidemiology and Biostatistics

University of California, San Francisco

500 Parnassus Street

San Francisco, California 94143

 

L. Barth Reller, M.D.

Professor of Medicine (Infectious Diseases)

Director of Clinical Microbiology

Duke University Medical Center

Box 3938

Durham, North Carolina 27710

 

Keith A. Rodvold, Pharm.D. (Acting Consumer Representative)

Professor of Pharmacy Practice

University of Illinois at Chicago

College of Pharmacy M/C 886

833 South Wood Street, Room 164

Chicago, Illinois 60612

 

 

 

 

 

 

 

 

 

 

Consultants (non-voting)

 

David G. Armstrong, DPM, MSc

Department of Surgery

Podiatry Section

Southern Arizona Veterans Affairs Medical Center

3601 South Sixth Avenue

Tucson, Arizona 85723

 

Allan R. Tunkel, M.D., Ph.D.

Associate Dean for Admissions

Professor of Medicine

Drexel University College of Medicine

2900 Queen Lane

Philadelphia, Pennsylvania 19129

 

Guest Speakers (non-voting)

 

Carl Norden, M.D.

Medical Director

Pfizer Inc.

Route 206

Bedminster, New Jersey

Dr. Tony Berendt, BM, BCh, FRCP

Consultant Physician-in-Charge

Bone Infection Unit

Deputy Medical Director

Nuffield Orthopaedic Centre

Oxford

OX3 7LD